Towards Neuroimmunotherapy for Cancer: the Neurotransmitters Glutamate, Dopamine and GnRH-II augment substantially the ability of T cells of few Head and Neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains

Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer

(2014) Assaf Marcus et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Benefits of a continuous therapy for cancer patients with a novel adoptive cell therapy by cascade priming (CAPRI)

(2014) Rudolf Wank et al.   Immunotherapy

The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells

(2014) Yonatan Ganor et al.   JOURNAL OF NEURAL TRANSMISSION

Exploiting the curative potential of adoptive T-cell therapy for cancer

(2013) Christian S. Hinrichs et al.   IMMUNOLOGICAL REVIEWS

Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

(2013) Mark E. Dudley et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes

(2012) Kevin M. Friedman et al.   JOURNAL OF IMMUNOTHERAPY

Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma

(2012) Anaëlle Duray et al.   LARYNGOSCOPE

Redirected tumor-specific allogeneic T cells for universal treatment of cancer

(2011) A. Marcus et al.   BLOOD

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

(2011) S. A. Rosenberg et al.   CLINICAL CANCER RESEARCH

Activated Monocytes Prime Naïve T Cells Against Autologous Cancer: Vigorous Cancer Destruction In Vitro and In Vivo

(2011) B. Laumbacher et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Treating cancer with genetically engineered T cells

(2011) Tristen S. Park et al.   TRENDS IN BIOTECHNOLOGY

Restoration of dysregulated CC chemokine signaling for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity

(2010) Krishnendu Chakraborty et al.   Cellular & Molecular Immunology

T Cell Activation

(2009) Jennifer E. Smith-Garvin et al.   Annual Review of Immunology

Organization of proximal signal initiation at the TCR:CD3 complex

(2009) Clifford S. Guy et al.   IMMUNOLOGICAL REVIEWS

Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes

(2009) J. Schmidtner et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Adoptive Cell Transfer in the Treatment of Metastatic Melanoma

(2009) Per thor Straten et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemiain vivo

(2009) Yonatan Ganor et al.   LEUKEMIA & LYMPHOMA

Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors

(2008) Mia Levite   CURRENT OPINION IN PHARMACOLOGY

Adoptive Cell Therapy for Patients with Melanoma, Using Tumor-Infiltrating Lymphocytes Genetically Engineered to Secrete Interleukin-2

(2008) Bianca Heemskerk et al.   HUMAN GENE THERAPY

CD3 ITAMs count!

(2008) Bernard Malissen   NATURE IMMUNOLOGY